UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer

Cancer science, 2016-09, Vol.107 (9), p.1193-1197

2016

Volltextzugriff (PDF)

cGAS-STING, an important pathway in cancer immunotherapy

Journal of hematology and oncology, 2020-06, Vol.13 (1), p.81-11, Article 81

2020

Volltextzugriff (PDF)

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy

Acta pharmaceutica Sinica. B, 2021-10, Vol.11 (10), p.2983-2994

2021

Volltextzugriff (PDF)

Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications

Chinese medical journal, 2022-05, Vol.135 (10), p.1203-1212

2022

Volltextzugriff (PDF)

Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine

Annals of nuclear medicine, 2022, Vol.36 (1), p.1-14

2022

Volltextzugriff (PDF)

TIM-3, a promising target for cancer immunotherapy

OncoTargets and therapy, 2018-01, Vol.11, p.7005-7009

2018

Volltextzugriff (PDF)

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2014-02, Vol.83 (2), p.146-153

2014

Volltextzugriff (PDF)

Early diagnosis of lung cancer: which is the optimal choice?

Aging (Albany, NY.), 2021-02, Vol.13 (4), p.6214-6227

2021

Volltextzugriff (PDF)

YAP1 expression is associated with survival and immunosuppression in small cell lung cancer

Cell death & disease, 2023-09, Vol.14 (9), p.636-636, Article 636

2023

Volltextzugriff (PDF)

Treatment of spine metastases in cancer: a review

Journal of International Medical Research, 2020-04, Vol.48 (4), p.300060519888107-300060519888107

2020

Volltextzugriff (PDF)

CD137, an attractive candidate for the immunotherapy of lung cancer

Cancer science, 2020-05, Vol.111 (5), p.1461-1467

2020

Volltextzugriff (PDF)

DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer

Frontiers in oncology, 2021-09, Vol.11, p.708294-708294

2021

Volltextzugriff (PDF)

Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer

Journal for immunotherapy of cancer, 2020-10, Vol.8 (2), p.e001391

2020

Volltextzugriff (PDF)

Combination of Baseline and Variation of Prognostic Nutritional Index Enhances the Survival Predictive Value of Patients With Advanced Non-Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitor

Clinical Medicine Insights. Oncology, 2022-01, Vol.16, p.117955492211371-11795549221137134

2022

Volltextzugriff (PDF)

Early detection of lung cancer by using an autoantibody panel in Chinese population

Oncoimmunology, 2018-02, Vol.7 (2), p.e1384108-e1384108

2018

Volltextzugriff (PDF)

T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients

Lung cancer (Amsterdam, Netherlands), 2014-06, Vol.84 (3), p.295-300

2014

Volltextzugriff (PDF)

Personalized tumor combination therapy optimization using the single-cell transcriptome

Genome medicine, 2023-12, Vol.15 (1), p.1-21, Article 105

2023

Volltextzugriff (PDF)

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment

Frontiers in oncology, 2021-11, Vol.11, p.713853-713853

2021

Volltextzugriff (PDF)

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)

Oncoimmunology, 2021-01, Vol.10 (1), p.1947665-1947665

2021

Volltextzugriff (PDF)

A follow-up study on factors affecting the recovery of patients with hypothyroidism in different selenium environments

BMC endocrine disorders, 2024-01, Vol.24 (1), p.14-14, Article 14

2024

Volltextzugriff (PDF)

FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002339

2021

Volltextzugriff (PDF)

Risk factors for nicotine dependence in Chinese patients with lung cancer

Journal of international medical research, 2019-01, Vol.47 (1), p.391-397

2019

Volltextzugriff (PDF)

Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach

Journal for immunotherapy of cancer, 2023-09, Vol.11 (9), p.e007492

2023

Volltextzugriff (PDF)

Epithelial phenotype as a predictive marker for response to EGFR‐TKIs in non‐small cell lung cancer patients with wild‐type EGFR

International journal of cancer, 2014-12, Vol.135 (12), p.2962-2971

2014

Volltextzugriff (PDF)

Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e002554

2021

Volltextzugriff (PDF)

1 – 25 von 1.908

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.478)
Mit Volltextzugriff
(1.482)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.150)
Life Sciences & Biomedicine
(806)
Humans
(312)
Physical Sciences
(281)
Technology
(277)
Female
(213)
Animals
(208)
Engineering
(162)
Male
(146)
Oncology
(139)
Mice
(136)
Science & Technology - Other Topics
(121)
Materials Science
(109)
Environmental Sciences & Ecology
(106)
Environmental Sciences
(103)
Chemistry
(102)
Immunology
(101)
Materials Science, Multidisciplinary
(87)
Biochemistry & Molecular Biology
(79)
Middle Aged
(78)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Lymphocyte‐activation gene‐3, an important immune checkpoint in cancer

cGAS-STING, an important pathway in cancer immunotherapy

Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy

Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications

Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine

TIM-3, a promising target for cancer immunotherapy

MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer

Early diagnosis of lung cancer: which is the optimal choice?

YAP1 expression is associated with survival and immunosuppression in small cell lung cancer

Treatment of spine metastases in cancer: a review

CD137, an attractive candidate for the immunotherapy of lung cancer

DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer

Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer

Combination of Baseline and Variation of Prognostic Nutritional Index Enhances the Survival Predictive Value of Patients With Advanced Non-Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitor

Early detection of lung cancer by using an autoantibody panel in Chinese population

T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients

Personalized tumor combination therapy optimization using the single-cell transcriptome

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC)

A follow-up study on factors affecting the recovery of patients with hypothyroidism in different selenium environments

FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III

Risk factors for nicotine dependence in Chinese patients with lung cancer

Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach

Epithelial phenotype as a predictive marker for response to EGFR‐TKIs in non‐small cell lung cancer patients with wild‐type EGFR

Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer

Suchergebnisse filtern